Top compounds associated with response to OR4K13


Feature Type Standardized
Nominal ANOVA
mRNA ruxolitinib GDSC1000 pan-cancer AAC -0.059 0.07
mRNA SNX-2112 GDSC1000 pan-cancer AAC -0.053 0.07
mRNA Imatinib GDSC1000 pan-cancer AAC -0.094 0.07
mRNA etoposide GDSC1000 pan-cancer AAC -0.061 0.08
mRNA JQ12 GDSC1000 pan-cancer AAC -0.061 0.08
mRNA vincristine CTRPv2 pan-cancer AAC 0.052 0.08
mRNA T0901317 GDSC1000 pan-cancer AAC 0.057 0.08
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.06 0.08
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.057 0.08
mRNA AZ628 GDSC1000 pan-cancer AAC -0.082 0.09
Download CSV